Hans-Norbert Topp to Take Over Management of the Gerresheimer Moulded Glass Business Unit

 - Gerresheimer AG
  • Internationally experienced manager with proven track record
  • Responsible for eight moulded glass plants across five countries 

 

Düsseldorf, July 31, 2025. Gerresheimer, an innovative system and solutions provider and global partner to the pharmaceutical, biotech, and cosmetics industries, has appointed Hans-Norbert Topp, an internationally experienced manager with a proven track record, as Head of its Moulded Glass Business Unit. The graduate economist has more than 30 years of leadership experience in various management positions. Topp began his career in the automotive industry and quickly assumed management responsibility. His career has included international management and executive positions in finance, controlling, and operations at Vaillant and SULO. He then joined SIXT, where he was a member of the Executive Board responsible for global sales. Since 2010, Hans-Norbert Topp has contributed his extensive experience as an independent manager and has served on the executive boards and as managing director of international companies in a wide range of industries. At Gerresheimer, he will take over as Executive Vice President Moulded Glass, assuming responsibility for the newly formed Moulded Glass business unit with eight production plants in five countries.

With the acquisition of Bormioli Pharma, Gerresheimer has expanded its moulded glass production network by two additional plants to a total of eight. Hans-Norbert Topp will use his many years of management experience and proven expertise in complex integration and transformation processes to further advance the formation of the global "Moulded Glass Powerhouse".

The combined moulded glass business of Gerresheimer and Bormioli Pharma generated pro forma revenues of around EUR 735 million in 2024 and has a diverse product portfolio for the pharmaceutical, cosmetics, food and beverage industries. 

 

About Gerresheimer  
Gerresheimer is an innovative systems and solutions provider and a global partner for the pharma, biotech and cosmetic industries. The Group offers a comprehensive portfolio of drug containment solutions including closures and accessories, as well as drug delivery systems, medical devices and solutions for the health industry. The product range includes digital solutions for therapy support, medication pumps, syringes, pens, auto-injectors and inhalers as well as vials, cartridges, ampoules, tablet containers, infusion, dropper and syrup bottles and more. Gerresheimer ensures the safe delivery and reliable administration of drugs to the patient. Gerresheimer supports its customers with comprehensive services along the value chain and in addressing the growing demand for enhanced sustainability. With over 40 production sites in 16 countries in Europe, America and Asia, Gerresheimer has a global presence and produces locally for regional markets. Together with Bormioli Pharma, the Group generated revenues of around EUR 2.4bn in 2024 and currently employs around 13,600 people. Gerresheimer AG is listed in the MDAX on the Frankfurt Stock Exchange (ISIN: DE000A0LD6E6).


Contact Gerresheimer AG

MediaInvestor Relations
Jutta Lorberg
Head of Corporate Communication
T +49 211 6181 264
jutta.lorberg-remove@remove-gerresheimer.com
Guido Pickert
Vice President Investor Relations
T +49 152 900 14145
gerresheimer.ir-remove@remove-gerresheimer.com
Marion Stolzenwald
Senior Manager Corporate Communication
T +49 172 2424185
marion.stolzenwald-remove@remove-gerresheimer.com
Thomas Rosenke 
Senior Manager Investor Relations 
T +49 211 6181-187 
gerresheimer.ir-remove@remove-gerresheimer.com

Contact us!

Communication & Marketing
Phone: +49 211 61 81 251
E-Mail: ueli.utzinger-remove@remove-gerresheimer.com